85 related articles for article (PubMed ID: 20466443)
1. Association of right heart with CA-125 levels in patients with heart failure.
Refiker M; Yilmaz MB
Int J Cardiol; 2010 Dec; 145(3):521-2. PubMed ID: 20466443
[No Abstract] [Full Text] [Related]
2. CA-125 and heart failure: déjà vu or "still to be seen".
Topatan B; Basaran A
Int J Cardiol; 2010 Dec; 145(3):626-9. PubMed ID: 21035210
[No Abstract] [Full Text] [Related]
3. Carbohydrate antigen-125: additional accuracy in identifying patients at risk of acute heart failure in acute coronary syndrome.
De Gennaro L; Brunetti ND; Bungaro R; Montrone D; Cuculo A; Pellegrino PL; Correale M; Di Biase M
Coron Artery Dis; 2009 Jun; 20(4):274-80. PubMed ID: 19440066
[TBL] [Abstract][Full Text] [Related]
4. CA125 and immunoinflammatory activity in acute heart failure.
Miñana G; Núñez J; Sanchis J; Bodí V; Núñez E; Llàcer A
Int J Cardiol; 2010 Dec; 145(3):547-8. PubMed ID: 20483181
[No Abstract] [Full Text] [Related]
5. CA 125 tumoral marker plasma levels relate to systolic and diastolic ventricular function and to the clinical status of patients with chronic heart failure.
Vizzardi E; Nodari S; D'Aloia A; Chiari E; Faggiano P; Metra M; Dei Cas L
Echocardiography; 2008 Oct; 25(9):955-60. PubMed ID: 18771557
[TBL] [Abstract][Full Text] [Related]
6. [CA-125 - does this next biomarker have a chance to hope for an expectation of risk stratification in patients with heart failure?].
Zieliński T
Kardiol Pol; 2010 Jul; 68(7):779-80. PubMed ID: 20648435
[No Abstract] [Full Text] [Related]
7. Prognostic value of CA125 in advanced heart failure patients.
Monteiro S; Franco F; Costa S; Monteiro P; Vieira H; Coelho L; Oliveira L; Providência LA
Int J Cardiol; 2010 Apr; 140(1):115-8. PubMed ID: 19285353
[TBL] [Abstract][Full Text] [Related]
8. Estimation of CA 125 concentration in patients with congestive heart failure.
Skórzyńska H; Solski J; Gernand W; Matras P; Gniwek M; Sokół M
Ann Univ Mariae Curie Sklodowska Med; 2004; 59(1):261-4. PubMed ID: 16145993
[TBL] [Abstract][Full Text] [Related]
9. The tumor marker CA-125 and heart failure.
Miñana G; Palau P; Núñez J; Sanchis J
Rev Esp Cardiol; 2010 Oct; 63(10):1213-4. PubMed ID: 20875366
[No Abstract] [Full Text] [Related]
10. CA-125 and heart failure: Déjà vu continues.
Topatan B; Basaran A
Int J Cardiol; 2011 Mar; 147(2):344-5. PubMed ID: 21255852
[No Abstract] [Full Text] [Related]
11. One biologic marker (carbohydrate antigen-CA 125), two different diseases (ovarian cancer and congestive heart failure): practical implications of monitoring CA 125 serum levels. A case report.
Faggiano P; D'Aloia A; Bignotti T; Dei Cas L
Ital Heart J; 2003 Jul; 4(7):497-9. PubMed ID: 14558304
[TBL] [Abstract][Full Text] [Related]
12. CA-125 for diagnosis of acute appendicitis: new possibility for an old tumor marker.
Basaran A
Colorectal Dis; 2010 Feb; 12(2):155-6. PubMed ID: 19799616
[No Abstract] [Full Text] [Related]
13. Tumour markers in chronic heart failure. Review of the literature and clinical implications.
Faggiano P; D'Aloia A; Antonini-Canterin F; Vizzardi E; Nicolosi GL; Cas LD
J Cardiovasc Med (Hagerstown); 2006 Aug; 7(8):573-9. PubMed ID: 16858234
[TBL] [Abstract][Full Text] [Related]
14. Antigen carbohydrate 125 in heart failure: not just a surrogate for serosal effusions?
Núñez J; Miñana G; González M; Garcia-Ramón R; Sanchis J; Bodí V; Núñez E; Chorro FJ; Llàcer A; Miguel A
Int J Cardiol; 2011 Feb; 146(3):473-4. PubMed ID: 21193243
[No Abstract] [Full Text] [Related]
15. [Increased carcinoembryonal antigen--a marker not only for ovarian cancer but also for heart failure].
Dixen U; Hassager C
Ugeskr Laeger; 2004 Nov; 166(48):4381-2. PubMed ID: 15587635
[No Abstract] [Full Text] [Related]
16. Serum carbohydrate antigen 125 has prognostic significance in heart failure, but no implications on treatment.
Beton O; Yucel O
Int J Cardiol; 2011 Sep; 151(2):241. PubMed ID: 21724271
[No Abstract] [Full Text] [Related]
17. Prognostic value of pleural effusion, CA-125 and NT-proBNP in patients with acute decompensated heart failure.
Davutoglu V; Yildirim C; Kucukaslan H; Yuce M; Sari I; Tarakcioglu M; Akcay M; Cakici M; Ceylan N; Al B
Kardiol Pol; 2010 Jul; 68(7):771-8. PubMed ID: 20648434
[TBL] [Abstract][Full Text] [Related]
18. Re: "clinical implications of a rising serum CA-125 within the normal range in patients with epithelial ovarian cancer: a preliminary investigation".
Menczer J
Gynecol Oncol; 2005 Mar; 96(3):906-7; author reply 907. PubMed ID: 15721450
[No Abstract] [Full Text] [Related]
19. Association between serum levels of soluble tumor necrosis factor receptors/CA 125 and disease progression in patients with epithelial ovarian malignancy: a gynecologic oncology group study.
Burger RA; Darcy KM; DiSaia PJ; Monk BJ; Grosen EA; Gatanaga T; Granger GA; Wang J; Tian C; Hanjani P; Cohn DE
Cancer; 2004 Jul; 101(1):106-15. PubMed ID: 15221995
[TBL] [Abstract][Full Text] [Related]
20. A difficult diagnosis: right unilateral cardiogenic pulmonary edema. Usefulness of biochemical markers of heart failure for the correct diagnosis.
D'Aloia A; Faggiano P; Brentana L; Boldini A; Procopio R; Racheli M; Dei Cas L
Ital Heart J; 2005 Sep; 6(9):771-4. PubMed ID: 16212082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
